We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Settles Provigil Dispute, Allowed to Launch in August
Mylan Settles Provigil Dispute, Allowed to Launch in August
June 19, 2012
Mylan can commence U.S. generic sales of the sleep disorder drug Provigil on Aug. 10, before the end of Teva’s 180-day marketing exclusivity period, under a settlement reached by the two companies.